The company is looking for a SME experienced in the medical/clinic area to develop together in a Eurostars project for early detection of patient deterioration.

A partner is sought for Eurostars R&D project concept to improve early detection of patient deterioration on general wards and during step-down / recovery at home. The idea is to combine continuous, medical-grade multi-parameter wearable monitoring with a risk-stratification layer that supports tiered escalation (advisory vs urgent) and integrates into existing hospital workflows rather than creating a separate “IT island”.

The project’s novelty is the translation of continuous physiological monitoring into an operational early-warning workflow that is practical for hospitals: reliable ingestion of high-frequency wearable data, robust handling of artefacts and dropouts, and standards-based interoperability so that summarised observations/alerts can be written back into the hospital EHR. A clinical partner in Sweden (University/Hospital environment) supports real-world validation and usability/evidence generation.

IPR conditions for the development:
Each consortium party retains ownership of its background IP and will contribute only assets it is entitled to use for the project. Foreground IP will be generated by the respective contributors according to standard Eurostars collaboration practice; interfaces will be defined contractually for project execution, and commercial licensing arrangements (if any) will be agreed after a positive grant decision. A targeted freedom-to-operate check will be performed prior to market launch.